Andrew Miller has quickly made his first move after the technology he invented, KarXT, secured an FDA approval last week. The ...

Alnylam Pharmaceuticals has agreed to drop its 2023 patent lawsuit against Moderna in a Delaware court following a judge's ...

This season’s uptake of RSV vaccines in the US has been slower than expected, according to Wall Street analysts tracking ...

The European Medicines Agency is looking more closely at medicines used to treat hair loss and a condition caused by an ...

Flagship Pioneering's roots in Singapore are growing less than a year after the biotech incubator first unveiled its ...

What’s left of Johnson & Johnson’s infectious disease work continues to shrink, after the company announced Friday that it ...

Eli Lilly’s blockbuster GLP-1 drug tirzepatide is finally back on track in the US after two years of intermittent shortages ...

Sanofi is offloading its rare autoimmune disease medicine Enjaymo to an Italian pharmaceutical company for $825 million ...

Telehealth companies and patients are grappling with the potential loss of access to cheaper, alternative versions of Eli ...

The weather is getting cooler, but biotech’s recovery is heating up. After a years-long wait-and-see game exhausted many ...

WuXi AppTec and WuXi Biologics are reportedly looking to sell part of their operations that have struggled because of ...

Kurma Partners has closed the first part of its latest biotech-focused fund, following a pair of M&A exits for drug ...